LAB: financial statements from SEC

Income statement

Metric	31/12/2025	31/12/2024
Revenue	85M	91M
Cost of revenue	43M	46M
Gross profit	43M	45M
Research and development	26M	29M
Selling, general and administrative	110M	103M
Operating expenses	153M	172M
Operating income	−110M	−127M
Interest expense	26,000	3M
Pre-tax income	−97M	−90M
Income tax	−38M	542,000
Net income	−75M	−139M
Earnings per share	−0.20	−0.52
Earnings per share, diluted	−0.20	−0.52
Weighted average shares	382M	353M
Weighted average shares, diluted	382M	353M

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	266M	121M	129M	159M	151M	167M	212M	271M
Receivables	17M	13M	14M	15M	35M	15M	35M	32M
Inventory	19M	20M	25M	24M	42M	21M	43M	43M
Current assets	521M	454M	472M	506M	344M	376M	454M	480M
Property, plant and equipment	17M	19M	21M	23M	44M	23M	42M	43M
Goodwill	—	—	—	—	112M	111M	106M	106M
Total assets	639M	568M	540M	557M	580M	612M	682M	709M
Current liabilities	42M	108M	108M	98M	56M	66M	121M	124M
Total liabilities	78M	143M	140M	132M	125M	141M	192M	198M
Equity	561M	424M	400M	425M	455M	472M	489M	510M
Shares outstanding	390M	386M	384M	382M	379M	378M	372M	371M
Shares issued	409M	405M	402M	400M	398M	396M	391M	390M
Treasury shares	19M	19M	19M	19M	19M	19M	19M	19M

Metric	31/12/2025	31/12/2024
Operating cash flow	−74M	−143M
Depreciation and amortisation	9M	13M
Share-based compensation	30M	32M
Capital expenditure	8M	8M
Investing cash flow	27M	363M
Share buybacks	0	40M
Financing cash flow	570,000	−103M